A comprehensive analysis of European competition law and intellectual property law issues affecting the pharmaceutical and biotechnology sectors, offering both theoretical and practical perspectives.
Part I: The Pharma and Biotech Business, Framework and Limitations; 1 The Context, Purpose and Limitation of the Book; 2 The Pharma Industry and its Business Strategies; 3 The Legal Framework, Concepts and Basic Principles and the Parallel Trade Regulation; Part II: The Function of Competition Law; 4 Pharma Agreements under Article 101 TFEU; 5 Dominance and Abuse; 6 Pharma Sector-Specific Abusive Conduct; 7 A short comparative analysis of the development under EU Competition law with the US development under the antitrust laws, i.e. Secs. 1 and 2 Sherman Act and Sec. 5 FTC Act.; Part III: Solutions and Reflections; 8 Competition within IPRs the solution to the problems now addressed under Competition law? - The way forward: Future developments, emerging issues and conclusions